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Lauren Broestl1, Nicole M. Warrington1, Lucia Grandison1, Tamara Abou-Antoun1, Olivia Tung1,
Saraswati Shenoy2, Miranda M. Tallman3,4, Gina Rhee1, Wei Yang5, Jasmin Sponagel 1, Lihua Yang1,
Najla Kfoury-Beaumont1,6, Cameron M. Hill1, Sulaiman A. Qanni1, Diane D. Mao7,8,9, Albert H. Kim 7,8,9,
Sheila A. Stewart 9,10,11,12, Monica Venere 3, Jingqin Luo 13 & Joshua B. Rubin 1,8 ✉

Males exhibit higher incidence and worse prognosis for the majority of cancers, including
glioblastoma (GBM). Disparate survival may be related to sex-biased responses to treatment,
including radiation. Using a mouse model of GBM, we show that female cells are more
sensitive to radiation, and that senescence represents a major component of the radiation
therapeutic response in both sexes. Correlation analyses revealed that the CDK inhibitor p21
and irradiation induced senescence were differentially regulated between male and female
cells. Indeed, female cellular senescence was more sensitive to changes in p21 levels, a
ﬁnding that was observed in wildtype and transformed murine astrocytes, as well as patientderived GBM cell lines. Using a novel Four Core Genotypes model of GBM, we further show
that sex differences in p21-induced senescence are patterned during early development by
gonadal sex. These data provide a rationale for the further study of sex differences in
radiation response and how senescence might be enhanced for radiation sensitization. The
determination that p21 and gonadal sex are required for sex differences in radiation response
will serve as a foundation for these future mechanistic studies.
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ex differences are observed in the majority of diseases,
including cancer. Across a wide range of ages and cultures,
male sex is associated with higher incidence and a worse
prognosis for most tumor types1–3. Glioblastoma (GBM), the
most common primary malignant brain tumor, follows this same
pattern—women are both less likely to develop GBM and have a
signiﬁcant survival advantage compared to men4–6. Sex differences in survival may result from differences in the response to
standard of care therapy, which for GBM includes surgical
resection, followed by treatment with radiation and chemotherapy. Previous research from our lab found that female GBM
patients had a greater decline in tumor growth velocity after
treatment with radiation and chemotherapy than male patients,
and that when these measures were used to stratify patients,
there was a signiﬁcant association with survival in female but not
male patients7. Furthermore, we identiﬁed unique molecular
pathways associated with improved survival in male and female
patients, and the expression of genes in these pathways correlated with the sensitivity to a range of chemotherapeutic agents7.
While this study advanced our understanding of the relationship
between chemotherapy and cellular responses in male and female
GBM, it did not focus on radiation, the backbone of GBM
treatment, which is currently applied to male and female patients
equally.
In cancer treatment, the goal is to stop tumor cell proliferation.
While one mechanism to achieve this is through triggering cell
death/apoptosis, another possibility is to activate cellular senescence—a cell fate decision that results in irreversible cell cycle
arrest8. Senescence is a known outcome of radiation treatment,
and at least one study has reported that this is the dominant
response in glioblastoma9. Senescence is often described as a
double-edged sword, since senescent cells secrete a broad variety
of factors with complex pro- and anti-tumorigenic effects10–12.
However, the cell-intrinsic aspect of senescence, speciﬁcally the
terminal cell cycle exit of cells harboring mutated DNA, serves a
beneﬁcial function in tumor prevention and treatment, and
enhancing this response could be a strategy to improve treatment
efﬁcacy.
Senescence is primarily regulated by two central pathways:
p53/p21WAF1/Cip1 and p16INK4A/Rb8,10,11. Importantly, we have
previously identiﬁed sex differences in the regulation of p21, p16,
and Rb in a GBM model, with female cells being more likely to
upregulate these pathways in response to cellular stress13,14.
Whether these differences inﬂuence the cellular response to
radiation in males and females is currently unknown. In this
study, we show that primary male and female human GBM lines
have unique molecular pathways that contribute to radiation
sensitivity. Using an in vitro mouse model of GBM, we ﬁnd that
females are more sensitive to radiation, and that senescence is a
major component of the radiation response in both males and
females. Using a correlation-based approach, we identify an
association between p21 and irradiation-induced cellular senescence that differs in males and females. The same levels of p21
correlate with higher percentages of senescent cells in females
than in males—a ﬁnding that was observed in both wild-type and
transformed cells, as well as in patient-derived GBM cell lines.
Finally, using a novel Four Core Genotypes (FCG) model of
GBM, we investigate the biological mechanisms underlying this
sex difference, and show that sex differences in p21-induced
senescence are patterned by gonadal sex.
Results
Unique molecular pathways contribute to radiation response
in male and female primary human GBM cell lines. Female
GBM patients exhibit signiﬁcantly longer median survival than
2

male patients5,15; concordantly, we previously determined that,
compared to males, female GBM patients exhibited a greater
initial therapeutic response to radiation and temozolomide
therapy7. Moreover, the degree of initial response to chemoradiation was signiﬁcantly correlated with survival in female, but
not male, patients. To investigate the molecular features underlying this sex difference in treatment response, we applied a Joint
and Individual Variance Explained (JIVE) algorithm to identify
and ﬁlter out gene expression patterns that were shared between
male and female patients. This revealed unique male and female
gene signatures that correlated with sex differences in survival, as
well as with sensitivity to a range of chemotherapeutic agents in
primary human GBM cell lines. Since our long-term goal is to
determine whether survival with GBM can be enhanced by
adapting treatment to sex differences in biology, to further
explore the clinical relevance of these gene signatures, we investigated whether they similarly correlated with sensitivity to
radiation.
We performed irradiation dose-response curves with four male
and ﬁve female primary human GBM lines (Supplementary
Table 1; Supplementary Fig. 1), and calculated an individual IC50
value for each line. As previously observed for other DNA
damaging agents, there was no signiﬁcant difference in the
median IC50 values for male and female lines (Fig. 1a).
Our previous work identiﬁed a set of differentially regulated
genes associated with better survival in either male (Male Cluster
5—MC5) or female (Female Cluster 3—FC3) GBM patients (see
Fig. 3a, b and Fig. 5c, d in ref. 7). Pathway analysis of these gene
sets identiﬁed enrichment of a cell cycle regulation pathway in
males (MC5—17 genes) and an integrin signaling pathway in
females (FC3—9 genes) (Supplementary Table 2). In both cases,
downregulation of the majority of genes in the pathway was
associated with improved survival7. We previously observed that
low expression of the MC5 gene set was associated with low IC50
for multiple chemotherapies in male cell lines, while low
expression of the FC3 gene set was associated with low IC50 for
multiple chemotherapies in female cell lines—a ﬁnding consistent
with the observation that downregulation of the MC5 and FC3
genes was associated with improved survival in male or female
GBM patients, respectively7. To determine whether these
molecular pathways may also be contributing to the male and
female irradiation response, we calculated Spearman rank
correlation coefﬁcients between IC50 values and the expression
levels for MC5 and FC3 genes, measured using the Illumina
HumanHT-12 v4 expression microarray. For the female cell lines,
we saw a similar pattern to that observed with other DNA
damaging agents (see Fig. 7b, c in ref. 7). There was a mild
positive correlation between FC3 gene expression and irradiation
IC50, indicating that low expression of these genes was associated
with low IC50, or better response to irradiation. There was also a
negative correlation between MC5 gene expression and IC50,
indicating that high expression of the MC5 genes was associated
with low IC50 (i.e. better response to irradiation) in the female
lines (Fig. 1b). In contrast, the male cell lines showed no
signiﬁcant correlation between MC5 gene expression and IC50,
while there was a signiﬁcant negative correlation between FC3
gene expression and IC50, indicating that high expression of the
FC3 genes was associated with better response to irradiation in
the male lines (Fig. 1b). Neither male nor female lines showed any
signiﬁcant correlation between IC50 and the expression levels of
randomly selected equally sized gene sets, serving as a negative
control. These results suggest that the response to radiation
therapy may be driven by different intracellular pathways in
males and females, and that efforts to improve response to
therapy may be advanced by identifying the mechanism(s)
underlying this sex difference.
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Fig. 1 Unique pathways contribute to cell-intrinsic radiation sensitivity in male and female human GBM lines. a Box plots of irradiation IC50 values for
four male and ﬁve female primary human GBM lines (horizontal bar indicates median). b Spearman correlation coefﬁcients of irradiation IC50 values with
expression of MC5 genes (17 genes), FC3 genes (9 genes), or random gene sets of the same size. For MC5 and FC3, box plots represent the distribution of
the correlation coefﬁcients for the 17 and 9 genes respectively. The colored square marks the average. For the random gene sets, the box plots represent
the distribution of the Olkin-averaged Spearman correlation coefﬁcient for 1000 gene sets of 17 (Male Cluster 5) or 9 (Female Cluster 3) randomly
selected genes. MC5: male p = 0.245, female p < 0.001. FC3: male p = 0.025, Female p = 0.083.

Female mouse GBM model astrocytes are more sensitive to
radiation treatment. To better understand the mechanisms
underlying radiation response in male and female GBM, we utilized an in vitro mouse model. This model consists of murine
astrocytes with loss of function of the tumor suppressors Nf1 and
p53 (Nf1−/− DNp53)13. When implanted intracranially, both
male and female cells form tumors that histologically resemble
high-grade gliomas, although the frequency of tumor formation
differs by cell sex13. In addition, this model displays sex differences in gene expression that are concordant with sex differences
in human GBM patient gene expression14. We performed irradiation dose response curves with male and female Nf1−/−
DNp53 astrocytes and found a signiﬁcant sex difference (Fig. 2a).
Female cells were more sensitive to irradiation, a ﬁnding consistent with results from GBM patients that suggest females are
more responsive to standard of care therapy (radiation and
chemotherapy)7.
To further assess sex differences in radiation sensitivity, we
irradiated male and female Nf1−/− DNp53 astrocytes with 0, 3,
or 9 Gy, then used live cell imaging to track cell growth for 3 days
(Fig. 2b). As previously reported13, in the absence of radiation
treatment male cells grew faster than female cells. While both
male and female cells showed impairment in growth after
irradiation with 9 Gy, only female cells showed a decline in
growth after treatment at the lower dose of 3 Gy (Fig. 2b). This
suggests that female GBM model astrocytes are more sensitive to
low dose irradiation. We next used the colony formation assay to
assess clonogenic survival following radiation treatment. Female
Nf1−/− DNp53 astrocytes had a greater decrease in colony
counts with radiation treatment than male Nf1−/− DNp53
astrocytes (Fig. 2c), further supporting the idea that female GBM
model cells are more sensitive to irradiation.
Finally, we assessed activation of the DNA damage response
(DDR) pathway by irradiating male and female Nf1−/− DNp53
astrocytes with 3 or 8 Gy and then performing immunoﬂuorescence for γH2AX, a marker of cellular response to DNA doublestrand breaks (Fig. 2d, e). We quantiﬁed the percent of cells with
>10 γH2AX foci at 1, 6, 24, and 48 h after irradiation (Fig. 2e). At
1 h after treatment, essentially 100% of male and female cells were
positive. Over time, the percent of positive cells declined
signiﬁcantly more rapidly and more completely in male

compared to female cells. At 48 h, ~10% of male cells treated
with 3 or 8 Gy irradiation had >10 γH2AX foci. In contrast,
female cells treated with 3 Gy or 8 Gy irradiation still had 25%
and 15% positivity for γH2AX foci, respectively, at 48 h.
Moreover, while radiation dose had no signiﬁcant effect on the
male cell response, there was a signiﬁcant difference in female cell
response to 3 versus 8 Gy. This suggests that radiation treatment
results in more persistent DDR activation in female cells. As
γH2AX foci can persist after resolution of double-strand breaks16,
differences in γH2AX staining do not necessarily reﬂect
differences in the efﬁciency or completeness of DNA repair.
The results do, however, indicate that there are sex differences in
DDR pathway activation and suggest that persistent DDR
activation may contribute to enhanced radiation sensitivity in
female cells.
Cell death and senescence contribute to sex differences in
radiation response in mouse GBM model astrocytes. Cell
response to DNA damage can vary. Cells may undergo: (1)
transient cell cycle arrest and repair of DNA damage, (2) apoptosis or other forms of cell death, or (3) permanent cell cycle
arrest in the form of senescence17. We focused on the two
mechanisms that result in durable therapeutic responses to cancer
therapy—apoptosis/cell death and senescence. To assess apoptosis, we ﬁrst measured levels of PARP and caspase-3 cleavage
following 0, 3, 6, or 8 Gy irradiation. Neither apoptosis marker
exhibited radiation dose response 24 h after treatment (Supplementary Fig. 2a). At 5 days post-treatment, caspase-3 (Fig. 3a),
but not PARP (Supplementary Fig. 2b), exhibited dose-dependent
cleavage in male cells only. These data suggest that apoptosis does
not underlie the increased female sensitivity to radiation.
Apoptosis is only one potential mechanism by which cells can
die following irradiation. In order to look more quantitatively at
cell death, we measured annexin V staining by ﬂow cytometry
24 h and ﬁve days after irradiation with 0, 3, 6, or 8 Gy (Fig. 3b,
Supplementary Fig. 2c, d). We observed a dose-dependent
increase in the annexin V positive fraction at both 24 h
(Supplementary Fig. 2d) and 5 days (Fig. 3b) after irradiation.
At 24 h there was no signiﬁcant effect of sex on annexin V
staining, while at 5 days females had higher levels of annexin V
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Fig. 2 Female mouse GBM model astrocytes are more sensitive to radiation treatment. a Irradiation dose response curves in male and female Nf1−/−
DNp53 astrocytes. Curves represent combined values from ﬁve separate established cell lines—each consisting of a corresponding male and female line
generated at the same time. Male IC50 = 5.567 (95% CI 5.094–6.088), female IC50 = 4.694 (95% CI 4.349–5.061). Two-way ANOVA: dose p < 0.0001,
sex p = 0.0123, interaction p = 0.6034. Open symbols are the means of the individual data points, which are presented as closed symbols. Lines are nonlinear ﬁts to the individual data points (n = 5/sex). b Male and female Nf1−/− DNp53 cell growth curves after irradiation with 0, 3, or 9 Gy. Cell growth
was tracked using live cell imaging; images were taken every 4 h for 3 days and used to calculate percent conﬂuence over time. Two-way repeated
measures ANOVA—male 0 Gy vs male 3 Gy: time p < 0.0001, dose p = 0.3394, interaction p = 0.9087; male 0 Gy vs male 9 Gy: time p < 0.0001, dose
p = 0.0325, interaction p < 0.0001; female 0 Gy vs female 3 Gy: time p < 0.0001, dose p = 0.0183, interaction p < 0.0001; female 0 Gy vs female 9 Gy: time
p < 0.0001, dose p = 0.05, interaction p < 0.0001. Open symbols are the means of the individual data points, which are presented as closed symbols. Lines
are non-linear ﬁts to the individual data points (n = 3/sex). c Normalized colony counts from the clonogenic assay in male and female Nf1−/− DNp53 cells
5 days after irradiation with 0, 4, 8, 12, or 16 Gy. Two-way ANOVA: dose p < 0.0001, sex p = 0.002, interaction p = 0.111. Open symbols are the means of
the individual data points, which are presented as closed symbols. (n = 3/sex). d Representative immunoﬂuorescence images of male and female Nf1−/−
DNp53 astrocytes stained for γH2AX 0, 1, 6, 24, and 48 h after irradiation with 3 Gy. Scale bar, 20 μm. e Quantiﬁcation of the percent of cells with >10
γH2AX foci at each timepoint in male and female Nf1−/− DNp53 astrocytes following irradiation with 3 or 8 Gy. Two-way ANOVA—male 3 Gy vs female
3 Gy: time p < 0.0001, sex p = 0.0004, interaction p = 0.0251; male 8 Gy vs female 8 Gy: time p < 0.0001, sex p = 0.0133, interaction p = 0.2784; female
3 Gy vs female 8 Gy: time p < 0.0001, dose p = 0.0168, interaction p = 0.2959.

positivity. As cell surface exposure of phosphotidylserine is now
recognized to be a feature of both apoptotic and non-apoptotic
modes of cell death18, the annexin V staining, together with the
cleaved caspase-3 results, suggest that irradiation leads to
increased non-apoptotic cell death in females compared to males,
which could contribute to greater female radiation sensitivity.
4

To evaluate the role of senescence in response to irradiation,
we stained cells for senescence-associated β-galactosidase (SA-βgal), the most widely used biomarker of senescence11,19,20, ﬁve
days after irradiation with 0, 3, 6, or 8 Gy. Quantiﬁcation of the
percentage of SA-β-gal positive cells revealed a clear, dosedependent increase in the percentage of senescent cells in both
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male and female Nf1−/− DNp53 astrocytes (Fig. 3c). There was a
signiﬁcant sex effect on SA-β-gal positivity, with higher levels of
senescent cells observed in females across the range of radiation
doses. Consistent with an increase in SA-β-gal, we also observed a
change in cell morphology after irradiation11,19, with a greater
percentage of cells appearing enlarged and irregular in shape, as
expected for senescence (Supplementary Fig. 3).
To provide further support that senescence was occurring, we
performed immunoﬂuorescence for the cell proliferation marker
Ki67 5 days after irradiation with 0, 3, 6, or 8 Gy (Fig. 3d,
Supplementary Fig. 4a). Ki67 positivity exhibited a signiﬁcant and
dose-dependent decrease after irradiation, again with a signiﬁcant

ARTICLE

effect of sex on the result. As senescence in response to DNA
damage involves cell cycle arrest, we directly measured the effects
of irradiation on DNA synthesis using ﬂow cytometry to measure
EdU incorporation. Concordant with the Ki67 and regrowth after
irradiation (Fig. 2b) data, female cells exhibited a continuous
decline in EdU incorporation over the entire dose range, while
male cells were relatively resistant to 3 Gy and only exhibited
substantial arrest at 8 Gy (Fig. 3e, Supplementary Fig. 4b). Finally,
we assessed expression levels of two genes that have previously
been identiﬁed as part of an ionizing radiation-induced
senescence (IRIS) signature that was shared across multiple cell
types and time points21. In agreement with this previous report,
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Fig. 3 Cell death and senescence contribute to sex differences in radiation response in mouse GBM model astrocytes. a Analysis of radiation-induced
caspase-3 cleavage. Representative western blot image of cleaved caspase-3 in male and female Nf1−/− DNp53 astrocytes 5 days after irradiation with 0,
3, 6, or 8 Gy; one male and one female cell line are shown. Cleaved caspase-3 (CC3) levels were ﬁrst normalized to their corresponding α-Tubulin values.
Then all CC3/α-Tubulin values were normalized to the corresponding Male 0 Gy condition of the same cell line, which was arbitrarily set at 1. Two-way
ANOVA: dose p = 0.0195, sex p = 0.0055, interaction p = 0.2085. Open symbols are the means of the individual data points, which are presented as
closed symbols (n = 9/sex/dose). Molecular weight markers (MW): Cleaved caspase-3 (15 kDa), α-Tubulin (50 kDa). b Analysis of radiation-induced
annexin V positivity. Sample histograms are shown for male (blue) and female (red) Nf1−/− DNp53 cells irradiated with 0, 3, or 8 Gy and stained for
annexin 5 days later. Quantiﬁcation of annexin V positivity 5 days after irradiation with 0, 3, 6, or 8 Gy. Values were normalized to the corresponding male
0 Gy condition of the same cell line, which was arbitrarily set at 1. Two-way ANOVA: dose p = 0.0077, sex p = 0.0464, interaction p = 0.8155. Open
symbols are the means of the individual data points, which are presented as closed symbols (n = 4/sex/dose) c Quantiﬁcation of the percentage of SA-βgal positive cells after irradiation with 0, 3, 6, or 8 Gy. Values were normalized to the corresponding Male 0 Gy condition of the same cell line, which was
arbitrarily set at 1. Two-way ANOVA: dose p < 0.0001, sex p = 0.0057, interaction p = 0.5356. Open symbols are the means of the individual data points,
which are presented as closed symbols (n = 4–5/sex/dose). d Percent of Ki67 positive cells in male and female Nf1−/− DNp53 cultures 5 days after
irradiation with 0, 3, 6, or 8 Gy. Values were normalized to the 0 Gy control condition for males and females separately. Two-way ANOVA: dose
p < 0.0001, sex p = 0.0002, interaction p = 0.08. Open symbols are the means of the individual data points, which are presented as closed symbols
(n = 3-5/sex/dose). e Analysis of EdU incorporation. Example density plots for EdU incorporation in male and female Nf1−/− DNp53 astrocytes under
control conditions or 24 h after irradiation with 8 Gy. These cultures have both 2 N and 4 N populations and S-phase Edu incorporation is indicated by black
gates. Quantiﬁcation of combined 2 N and 4 N EdU incorporation 24 h after irradiation with 0, 3, 6, or 8 Gy. Values were normalized to the 0 Gy control
condition for males and females separately. Two-way ANOVA: dose p < 0.0001, sex p = 0.001, interaction p = 0.177. Open symbols are the means of the
individual data points, which are presented as closed symbols (n = 4/sex/dose).

we observed an increase in expression of Ccnd1 (Cyclin D1) and a
decrease in expression of Cdkn1b (p27) 5 days after irradiation in
both male and female Nf1−/− DNp53 astrocytes (Supplementary
Fig. 4c, d). Together, these ﬁndings indicate that cell cycle arrest
and senescence are a central component of the response to
irradiation in Nf1−/− DNp53 astrocytes. Sex had a signiﬁcant
effect across multiple measures of the senescence response,
including SA-β-gal, Ki67, and EdU incorporation, indicating that
female cell sex is associated with greater senescence in response to
irradiation compared to male cells.
Together these results demonstrate that at 5 days after
irradiation female cells have increased levels of cell death and
senescence compared to male cells. Both of these processes could
contribute to sex differences in radiation sensitivity. Intriguingly,
while we saw no sex differences in cell death 24 h after irradiation,
female cells did undergo greater cell cycle arrest compared to
males. This suggests there may be sex differences in the early
activation of pathways that lead to arrest, and eventually
senescence, following irradiation.
Expression of p21 24 h after irradiation correlates with the
senescence response observed at 5 days. Two critical pathways
for the induction of cell cycle arrest and cellular senescence are
the p16INK4A/Rb and p53/p21WAF1/Cip1 pathways10,11. The
Nf1−/− DNp53 astrocytes express a dominant negative p53,
which has been demonstrated to abrogate canonical wild-type
p53 transcriptional activity13,22. Nonetheless, we have shown that
these cells retain the ability to upregulate p21 in response to DNA
damage14, presumably through p53-independent mechanisms23.
To better understand the contributions of the p16INK4A/Rb and
p53/p21WAF1/Cip1 pathways to senescence induction following
irradiation, we used qPCR to measure expression levels of Cdkn2a
(p16) and Cdkn1a (p21) 24 h after treatment of cells with 0, 6, or
9 Gy (for nomenclature clariﬁcation, we will use the gene name
(Cdkn2a, Cdkn1a) when referring to mRNA expression levels,
and the protein name (p16, p21) when referring to protein
expression levels). We then correlated these values with the
percentage of cells that were SA-β-gal positive at 5 days. Because
our lab has previously identiﬁed sex differences in the regulation
of both p16 and p21 in Nf1−/− DNp53 astrocytes14, we looked at
the relationship between these two measures and senescence in
males and females separately. Cdkn2a levels 24 h after irradiation
showed no signiﬁcant correlation with the senescence response at
6

5 days in either males or females (Fig. 4a, Supplementary
Table 3). In contrast, levels of Cdkn1a signiﬁcantly correlated
with the percent of SA-β-gal positive cells in both males (r = 0.59)
and females (r = 0.79) (Fig. 4b, Supplementary Table 3). This
suggests that early upregulation of p21, but not p16, contributes
to the senescence response following irradiation in mouse GBM
astrocytes. This is consistent with previous research from our lab,
which found that in response to treatment with the DNA
damaging agent etoposide, levels of p21, but not p16, increased in
Nf1−/− DNp53 cells14. To conﬁrm that increased p21 expression
was independent of the wild-type p53 alleles in our cell model, we
directly measured the endogenous p53 levels 24 h and ﬁve days
following irradiation with 0, 3, 6, or 8 Gy. Whereas p21 expression was induced by irradiation in male and female Nf1−/−
DNp53 cells, there was no concomitant induction of p53 (Supplementary Fig. 5).
Downstream of p21 is the cyclin-dependent kinase Cdk2, and
it is through inhibition of Cdk2 that p21 primarily acts to
maintain Rb in a hypo-phosphorylated state24,25, a critical step in
cell cycle arrest and senescence induction11. In addition, it has
been reported that the p21/Cdk2 ratio is the primary determinant
of the senescent fate decision in human ﬁbroblasts following
irradiation26. To assess whether the p21/Cdk2 ratio may similarly
inﬂuence the induction of senescence in our mouse GBM model
cells, we measured levels of Cdk2 mRNA 24 h after irradiation
and correlated the Cdkn1a/Cdk2 ratio with the percent of SA-βgal positive cells at 5 days (Fig. 4c, Supplementary Table 3). We
found that the Cdkn1a/Cdk2 ratio signiﬁcantly correlated with
SA-β-gal positivity in both males (r = 0.53) and females
(r = 0.80).
p21 differentially correlates with SA-β-gal positivity in male
and female mouse GBM model astrocytes. We next sought to
determine whether the correlation between the p21/Cdk2 ratio
and senescence was also observed at the protein level, and whether this relationship was maintained at later timepoints, once
senescence was established. To this end, we measured p21 and
Cdk2 levels by western blot, 24 h and 5 days after irradiation with
0, 3, 6, and 8 Gy (Fig. 4d–f). Surprisingly, while p21/Cdk2 protein
levels at 24 h signiﬁcantly correlated with SA-β-gal positivity in
females (r = 0.52, p = 0.0029), this was not the case for males
(r = 0.30, p = 0.997) (Fig. 4e, Supplementary Table 3). Even more
striking, while p21/Cdk2 protein levels at 5 days did correlate
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Fig. 4 Expression of p21 differentially correlates with SA-β-gal positivity in male and female mouse GBM model astrocytes. a Correlation between
Cdkn2a (p16) mRNA levels at 24 h after irradiation with 0, 6, or 9 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and
female Nf1−/− DNp53 astrocytes (n = 15/sex). b Correlation between Cdkn1a (p21) mRNA levels at 24 h after irradiation with 0, 6, or 9 Gy and the
percentage of SA-β-gal positive cells at 5 days after irradiation in male and female Nf1−/− DNp53 astrocytes. Male correlation: r = 0.59, p = 0.0212;
Female correlation: r = 0.79, p = 0.0005 (n = 15/sex). c Correlation between the Cdkn1a/Cdk2 mRNA ratio at 24 h after irradiation with 0, 6, or 9 Gy and
the percentage of SA-β-gal positive cells at 5 days after irradiation in male and female Nf1−/− DNp53 astrocytes. Male correlation: r = 0.53, p = 0.0427;
Female correlation: r = 0.80, p = 0.0003 (n = 15/sex). d Representative western blot images of p21 and Cdk2 5 days post-irradiation with 0, 3, 6, or 8 Gy.
One male and one female Nf1−/− DNp53 cell line are shown. Molecular weight markers (MW): p21 (15 kDa), Cdk2 (30 kDa). e Correlation between the
p21/Cdk2 protein ratio at 24 h after irradiation with 0, 3, 6, or 8 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and
female Nf1−/− DNp53 astrocytes. Male correlation: r = 0.30, p = 0.0997, female correlation: r = 0.52, p = 0.0029, male slope vs female slope:
p = 0.0627—indicated by bracket (n = 31/sex). f Correlation between the p21/Cdk2 protein ratio 5 days after irradiation with 0, 3, 6, or 8 Gy and the
percentage of SA-β-gal positive cells at 5 days after irradiation in male and female Nf1−/− DNp53 astrocytes. Male correlation: r = 0.40, p = 0.0239,
female correlation: r = 0.65, p < 0.0001, male slope vs female slope: p = 0.009—indicated by bracket (n = 31/sex).

with the percentage of SA-β-gal positive cells in both males
(r = 0.40, p = 0.0239) and females (r = 0.65, P < 0.0001), it was
with signiﬁcantly different slopes (p = 0.009) (Fig. 4f, Supplementary Table 3). Thus, the same level of p21/Cdk2 expression at
5 days corresponded to higher levels of senescence in females
than in males, as measured by SA-β-gal. This suggests that not
only does the p21/Cdk2 ratio play a role in the maintenance of
senescence following irradiation, but that there may be a sex
difference in sensitivity to p21/Cdk2 levels and/or that p21 may
be playing a greater role in irradiation-induced senescence in
female GBM cells than in male GBM cells.

Wild-type mouse astrocytes exhibit sex differences in the
relationship between p21 and SA-β-gal. We wondered whether
the sex difference in the relationship between p21 and SA-β-gal
that we observed in our mouse GBM model represents a more
fundamental sex difference, present in normal astrocytes, or is
unique to transformed cells and the loss of p53 function. To
address this question, we isolated astrocytes from the cortex of
male and female postnatal day 1 C57Bl6 mouse pups. Astrocytes
from each pup were cultured independently and split to allow
for corresponding measures of SA-β-gal and collection of RNA or
protein. We irradiated these wild-type (WT) astrocytes with 0 or
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10 Gy, then collected RNA or protein 24 h later, and stained for
SA-β-gal at 7 days (Fig. 5a). The irradiation dose and time until
SA-β-gal measurement were increased to adjust for the much
slower division rate of wildtype astrocytes compared to Nf1−/−
DNp53 astrocytes. Even in the untreated condition, wildtype
astrocytes exhibited measurable levels of senescence, reﬂective of
their limited replicative potential (Fig. 5a). Quantiﬁcation of the
percentage of SA-β-gal positive cells conﬁrmed a signiﬁcant
increase following irradiation in both male and female wildtype
astrocytes (Fig. 5b). To conﬁrm that cells were undergoing G1
arrest, consistent with senescence, we performed immunoﬂuorescence for geminin, which is absent during G1 and accumulates during S, G2, and M phases of the cell cycle. We counted
the numbers of geminin-positive male and female cells per highpowered ﬁeld (hpf) 7 days post-treatment. As expected, the
number of geminin-positive cells signiﬁcantly decreased in both
male and female astrocytes in response to irradiation (Fig. 5c).
We used qPCR to measure expression levels of Cdkn2a (p16)
and Cdkn1a (p21) mRNA at 24 h after irradiation, then correlated
these measures with the corresponding SA-β-gal percentage. As
expected, Cdkn2a levels did not signiﬁcantly correlate with SA-βgal positivity in either male or female WT astrocytes (Fig. 5d,
Supplementary Table 3), conﬁrming that p16 upregulation is not
a primary driver of senescence induction in astrocytes following
irradiation. In contrast, Cdkn1a levels did signiﬁcantly correlate
with the percent of SA-β-gal positive cells at 7 days, however, only
in females (female r = 0.79, male r = 0.28) (Fig. 5e, Supplementary Table 3). When we looked at the relationship between the
Cdkn1a/Cdk2 ratio and SA-β-gal, we once again found a
signiﬁcant correlation in female WT astrocytes (r = 0.94), but
only a non-signiﬁcant mild correlation in male WT astrocytes
(r = 0.39) (Fig. 5f, Supplementary Table 3). As with the Nf1−/−
DNp53 astrocytes, the female WT astrocytes had a steeper slope
for both Cdkn1a and Cdkn1a/Cdk2 vs SA-β-gal compared to
males, although this did not reach statistical signiﬁcance.
To determine whether the sex difference in the relationship
between p21 expression and SA-β-gal was maintained at the
protein level, we measured p21 and Cdk2 protein levels by
western blot (Fig. 5g), then correlated these with the percent of
SA-β-gal positive cells at 7 days. Both p21 alone, and the p21/
Cdk2 ratio, signiﬁcantly correlated with senescence in female WT
astrocytes (r = 0.67 and r = 0.53, respectively), but not male WT
astrocytes (Fig. 5h, i, Supplementary Table 3). These results
suggest that p21 may be playing a greater role in senescence
induction in female astrocytes than in male astrocytes following
irradiation, and that this is occurring regardless of whether the
cells are transformed or not.
Sex differences in senescence are observed in wild-type astrocytes with advanced population doublings. In initial studies to
assess the effects of treatment-induced senescence in wild-type
astrocytes, we observed that with successive population doubling
levels (PDLs) a baseline sex difference in senescence began to
emerge – with females having higher percentages of SA-β-gal
positive cells than males in the untreated condition. To assess this
more directly, we cultured male and female wildtype astrocytes
and stained for SA-β-gal when the cells were at either low (5–7)
versus high (12–14) PDLs (Supplementary Fig. 6a). At 12–14
PDLs, wild-type astrocytes showed a dramatic decrease in growth,
with the majority of cells adopting an enlarged, ﬂattened, irregular morphology, and were unable to be passaged further.
Male and female wild-type astrocytes proliferate at equal rates,
and thus we were able to make ready comparisons between the
senescent cell fractions as a function of PDLs in male and female
cultures. At low (5–7) PDLs, the ratio of SA-β-gal positive cells
8

(female/male) was ~1, indicating equivalent levels of senescent
cells in male and female astrocyte cultures (Supplementary
Fig. 6b). At higher (12–14) PDLs, this ratio was signiﬁcantly
increased, indicating higher percentages of senescent cells in
female cultures. Thus, female mouse astrocytes undergo senescence more frequently than male mouse astrocytes with increased
PDLs. Whether the higher rates of senescence in female wild-type
astrocyte cultures reﬂect sex differences in the propensity to
undergo replicative senescence or in the sensitivity to oxidative
damage, resulting from culture at 20% oxygen27, remains to be
determined. However, this suggests that sex differences may
extend to other senescence paradigms and phenotypes, and
highlights the need to study these in both sexes separately.
Primary human GBM lines exhibit sex differences in the
relationship between p21/Cdk2 and SA-β-gal. We next assessed
whether sex differences in the role of p21 in irradiation-induced
senescence extended to human GBM. For this purpose, we utilized the same primary human GBM lines used to correlate
irradiation sensitivity with expression of the MC5 and FC3 gene
sets. We irradiated each male and female line with 0 or 6 Gy and
stained for SA-β-gal 5 days later. The 6 Gy dose was chosen based
on the human GBM irradiation dose response curves; it was
above the mean IC50 value for both sexes, but lower than the dose
at which most lines showed a plateau in response (Supplementary
Fig. 1). There was a signiﬁcant increase in the percent of SA-β-gal
positive cells following irradiation in both male and female
human GBM (Fig. 6a).
Using protein samples collected 24 h and 5 days after
irradiation, we measured levels of p21 and Cdk2 by western blot
(Fig. 6b). At 24 h, both p21 alone (Fig. 6c) and the p21/Cdk2 ratio
(Fig. 6d) signiﬁcantly correlated with the percent of SA-β-gal
positive cells at 5 days in female human GBM lines (r = 0.85 for
both), but only moderately correlated in male human GBM lines
(r = 0.23 and r = 0.54, respectively) (Supplementary Table 3).
This same pattern was observed at 5 days, with p21 and p21/
Cdk2 signiﬁcantly correlating with SA-β-gal for female (r = 0.83
and r = 0.84, respectively) but not male lines (r = -0.09 and
r = −0.27, respectively) (Fig. 6e, f, Supplementary Table 3). Given
the small number of human GBM specimens, we considered
whether these correlations were being driven by outlier versus
leverage points28. We concluded that these were leverage points
as they were characterized by having “extreme” x and y values
that followed the overall linear relationship. In addition, they
were consistent with what we observed in the wild-type and
transformed murine models. Thus, in both mouse and human,
transformed and wild-type astrocytes, the relationship between
p21 and senescence, as measured by SA-β-gal, differs between
males and females.
Knockdown of p21 abrogates sex differences in senescence and
DNA damage response in irradiated mouse GBM model
astrocytes. To further test the role of p21 in senescence in irradiated male and female cells, we utilized an Nf1−/− DNp53 p21
knockdown line previously developed in our lab using CRISPR/
Cas914. We conﬁrmed knockdown by irradiating Cas9 and p21
KD cells with 0 or 8 Gy and measuring levels of p21 protein 24 h
later. Both male and female p21 KD lines had a strong reduction
in p21 levels—less than 30% of control levels (Supplementary
Fig. 7a, b). We then irradiated male and female Cas9 and p21 KD
cells with 0, 3, 6, or 8 Gy and stained for SA-β-gal 5 days later
(Fig. 7a). Once again, in control Cas9 cells, females exhibited a
greater dose-dependent senescence response than males (Fig. 7b).
The male response was unaffected by p21 knockdown (Fig. 7c). In
contrast, p21 knockdown in female cells resulted in a signiﬁcant
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Fig. 5 Wild-type mouse astrocytes exhibit sex differences in the relationship between p21 and SA-β-gal positivity. a Example images of wildtype mouse
astrocytes stained for SA-β-gal seven days after irradiation with 0 or 10 Gy, followed by counterstaining with nuclear fast red. Scale bar, 150 μm.
b Quantiﬁcation of the percentage of SA-β-gal positive cells. Results are pooled from 3 separate experiments, representing a total of 17 male and 23 female
pups across 7 litters. Values were normalized to the Male 0 Gy condition of the same experiment, which was arbitrarily set at 1. Two-way ANOVA: dose
p < 0.0001, sex p = 0.0455, interaction p = 0.3676. **p < 0.01, ****p < 0.0001 as indicated by bracket. Data are means +/− SEM (n = 17–23/sex/
condition). c Number of Geminin positive nuclei per high-powered ﬁeld. Shown are the means +/− SEM and each of the individual replicate points (n = 5/
sex/condition). Two-way ANOVA: dose p < 0.0001, sex p = 0.3948, interaction p = 0.5561. *p = 0.0145 and **p = 0.0024 as indicated by bracket.
d Correlation between Cdkn2a (p16) mRNA levels at 24 h after irradiation with 0 or 10 Gy and the percentage of SA-β-gal positive cells at 7 days after
irradiation in male and female wildtype astrocytes (n = 10 male/8 female). e Correlation between Cdkn1a (p21) mRNA levels at 24 h after irradiation with 0
or 10 Gy and the percentage of SA-β-gal positive cells at 7 days after irradiation in male and female wildtype astrocytes. Male correlation: r = 0.28,
p = 0.441, female correlation: r = 0.79, p = 0.0207 (n = 10 male/8 female). f Correlation between the Cdkn1a/Cdk2 mRNA ratio at 24 h after irradiation
with 0 or 10 Gy and the percentage of SA-β-gal positive cells at 7 days after irradiation in male and female wild-type astrocytes. Male correlation: r = 0.39,
p = 0.2608, Female correlation: r = 0.94 p = 0.0005 (n = 10 male/8 female). g Representative western blot images of p21 and Cdk2 in non-irradiated and
irradiated male and female wild-type astrocytes at 24 h, and irradiated male and female wild-type astrocytes at 7 days. Molecular weight markers (MW):
p21 (15 kDa), Cdk2 (30 kDa), α-Tubulin (50 kDa). h Correlation between p21 protein levels at 24 h after irradiation with 0 or 10 Gy and the percentage of
SA-β-gal positive cells at 7 days after irradiation in male and female wild-type astrocytes. Male correlation: r = 0.33, p = 0.2909, female correlation:
r = 0.67, p = 0.0003 (n = 12 male/24 female). i Correlation between the p21/Cdk2 protein ratio at 24 h after irradiation with 0 or 10 Gy and the
percentage of SA-β-gal positive cells at 7 days after irradiation in male and female wildtype astrocytes. Male correlation: r = 0.20, p = 0.5418, Female
correlation: r = 0.53, p = 0.0081 (n = 12 male/24 female).
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Fig. 6 Primary human GBM lines exhibit sex differences in the relationship between p21 and SA-β-gal positivity. a Fold change (irradiated/control) in
the percentage of SA-β-gal positive cells 5 days after irradiation with 0 or 6 Gy in four male and four female primary human GBM lines. *p = 0.0329 (male)
and *p = 0.0401 (female). b Representative western blot images of p21 and Cdk2 24 h and 5 days after irradiation with 0 or 6 Gy in male and female
human GBM lines. Molecular weight markers (MW): p21 (15 kDa), Cdk2 (30 kDa), α-Tubulin (50 kDa). c Correlation between p21 protein levels at 24 h
after irradiation with 0 or 6 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and female human GBM lines. Male
correlation: r = 0.23, p = 0.5783, female correlation: r = 0.85, p = 0.008 (n = 8/sex). d Correlation between the p21/Cdk2 protein ratio at 24 h after
irradiation with 0 or 6 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and female human GBM lines. Male correlation:
r = 0.54, p = 0.1649, female correlation: r = 0.85, p = 0.0081 (n = 8/sex). e Correlation between p21 protein levels at 5 days after irradiation with 0 or
6 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and female human GBM lines. Male correlation: r = −0.09,
p = 0.8408, female correlation: r = 0.83, p = 0.0115 (n = 8/sex). f Correlation between the p21/Cdk2 protein ratio at 5 days after irradiation with 0 or 6 Gy
and the percentage of SA-β-gal positive cells at 5 days after irradiation in male and female human GBM lines. Male correlation r = −0.27, p = 0.5179,
female correlation: r = 0.84, p = 0.0099 (n = 8/sex).

reduction in the percent of SA-β-gal positive cells as a function of
radiation dose, to levels comparable to those of male cells
(Fig. 7d).
To determine whether p21 knockdown would also exhibit a
sex-biased effect on DDR, we quantiﬁed γH2AX foci resolution in
Cas9 control and p21 KD Nf1−/− DNp53 astrocytes following
irradiation with either 3 or 8 Gy. Consistent with our ﬁndings in
10

Fig. 2e, female Cas9 control cells exhibited sustained γH2AX foci
compared to male Cas9 control cells (Fig. 7e). Similar to the
effects of p21 knockdown on senescence, the kinetics and
magnitude of γH2AX foci resolution following irradiation with
3 or 8 Gy was unaffected by p21 status in male cells (Fig. 7f). In
contrast, the kinetics and magnitude of γH2AX foci resolution
after treatment with 8 Gy were signiﬁcantly increased in female
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cells by p21 KD (Fig. 7g) to male comparable levels. There was a
trend towards an effect of p21 KD in female cells irradiated with
3 Gy, however this did not reach statistical signiﬁcance. Together,
these data support the idea that p21 expression contributes
signiﬁcantly to the levels of senescence after irradiation in
females, but not in males. Notably, despite the decrease in SA-βgal in female p21 KD cells, they still retain a signiﬁcant
senescence response, and in fact decrease only to the levels of
senescence in male cells. This suggests that additional pathways,
beyond p21, are contributing to senescence after irradiation in
both male and female cells.

ARTICLE

The four core genotypes mouse model can be used to interrogate the developmental mechanisms underlying sex differences. Multiple mechanisms can potentially underlie an observed
sex difference: (1) acute differences in circulating gonadal hormone levels, (2) organizational/epigenetic effects of gonadal
hormone exposure in utero, and (3) differences in the expression
levels of genes on the X and Y chromosomes29. The sex difference
in the relationship between p21 and SA-β-gal that we observe is
present in vitro, with male and female cells grown in identical
media. Thus, it is unlikely that the differences in p21 are driven
by effects of circulating estrogen or testosterone. To investigate
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Fig. 7 p21 knockdown abrogates sex differences in senescence and DNA damage response in irradiated mouse GBM model astrocytes. a Example
images of Nf1−/− DNp53 Cas9 control and p21 knockdown (KD) male and female astrocytes stained for SA-β-gal 5 days after irradiation with 0 or 8 Gy,
followed by counterstaining with nuclear fast red. Scale bar, 150 μm. b–d Quantiﬁcation of the percentage of SA-β-gal positive cells 5 days post-irradiation
with 0, 3, 6, or 8 Gy. Values were normalized to the corresponding Male 0 Gy condition of the same cell line, which was arbitrarily set at 1. b Male vs female
Cas9 control cells—two-way ANOVA: dose p < 0.0001, sex p < 0.0001, interaction p = 0.2093. c Male Cas9 vs male p21 KD - two-way ANOVA: dose
p < 0.0001, genotype p = 0.1459, interaction p = 0.8529; d Female Cas9 vs female p21 KD: two-way ANOVA: dose p < 0.0001, genotype p = 0.0093,
interaction p = 0.5635. Male Cas9 curve (blue) is shown for comparison. Open symbols are the means of the individual data points, which are presented as
closed symbols (b–d n = 6–9/sex/dose). e–g Quantiﬁcation of the percent of Nf1−/− DNp53 Cas9 control versus p21 knockdown (KD) cells with >10
γH2AX foci at 1, 6, 24, and 48 h following irradiation with 3 Gy (top row) or 8 Gy (bottom row). Two-way ANOVAs: e Male Cas9 versus female Cas9 at
3 Gy: time: p < 0.0001, sex: p = 0.079, interaction: p = 0.625; male Cas9 versus female Cas9 at 8 Gy: time: p < 0.0001, sex: p = 0.0014, interaction:
p = 0.0524. f Male Cas9 versus p21 KD at 3 Gy: time p < 0.0001, genotype: p = 0.356, interaction: p = 0.775; male Cas9 versus p21 KD at 8 Gy: time
p < 0.0001, genotype: p = 0.0645, interaction: p = 5773 g female Cas9 versus p21 KD at 3 Gy: time p < 0.0001, genotype: p = 0.205, interaction:
p = 0.774; female Cas9 versus p21 KD at 8 Gy: time p < 0.0001, genotype: p = 0.006, interaction: p = 0.0418. Open symbols are the means of the
individual data points, which are presented as closed symbols (e–g n = 3/sex/timepoint).

whether organizational effects or sex chromosomes are responsible, we utilized a transgenic mouse model known as the Four
Core Genotypes (FCG) model30. In the FCG model, the Sry gene,
which encodes the testis-determining factor, is deleted from the Y
chromosome and inserted onto an autosome, allowing for the
separation of gonadal and chromosomal sex. Crossing XY−/Sry+
males with normal XX females results in mice of four genotypes:
XY−/Sry+ (XY with testes—normal male), XY−/Sry− (XY with
ovaries), XX/Sry+ (XX with testes), and XX/Sry− (XX with ovaries
—normal female) (Fig. 8a). Mice that inherit the Sry gene,
regardless of chromosomal sex, develop testes and are exposed to
masculinizing levels of gonadal hormones during in utero development. Mice that lack the Sry gene develop ovaries and display
phenotypes associated with a feminized brain30. We crossed FCG
XY−/Sry+ mice with Cas9 expressing female (XX) mice and isolated astrocytes from the postnatal day 1 pups. We then used
CRISPR/Cas9 to delete Nf1 and p53 from these astrocytes,
mimicking our Nf1−/− DNp53 GBM model (Supplementary
Fig. 8).
Gonadal sex patterns the relationship between p21 and SA-βgal positivity. Using our newly developed FCG GBM model, we
irradiated the cells with 0 or 8 Gy and then stained for SA-β-gal
5 days later (Fig. 8b). The percentage of SA-β-gal positive cells
increased following irradiation in all four genotypes (Fig. 8c),
although due to high variability, this did not reach signiﬁcance in
the XY+ genotype. Using qPCR, we measured levels of Cdkn1a
(p21) mRNA expression 24 h after irradiation and correlated this
with the percent of SA-β-gal positive cells at 5 days (Fig. 8d, left,
Supplementary Table 3). To better evaluate whether sex chromosomes or gonadal sex determines the relationship between p21
and SA-β-gal, we grouped the genotypes based on these factors
and then compared XY vs XX (Fig. 8d, center, Supplementary
Table 3) and Sry+ vs Sry− (Fig. 8d, right, Supplementary
Table 3). When the genotypes were grouped based on sex chromosomes, Cdkn1a did not signiﬁcantly correlate with SA-β-gal in
either XY or XX FCG GBM model cells. However, when the
genotypes were grouped based on gonadal sex, Cdkn1a expression
signiﬁcantly correlated with SA-β-gal positivity in Sry− cells
(r = 0.91), but not Sry+ cells (r = 0.13).
We next measured Cdk2 levels by qPCR and correlated the
Cdkn1a/Cdk2 ratio with SA-β-gal percentage (Fig. 8e, left,
Supplementary Table 3). When we grouped the genotypes based
on sex chromosomes, we again observed that the Cdkn1a/Cdk2
ratio did not correlate with SA-β-gal in either XY or XX cells
(Fig. 8e, center, Supplementary Table 3). In contrast, when we
grouped the genotypes based on gonadal sex, the Cdkn1a/Cdk2
ratio signiﬁcantly correlated with SA-β-gal in Sry− cells
(r = 0.91), but not Sry+ cells (r = −0.22) (Fig. 8e, right,
12

Supplementary Table 3). In addition, when we compared the
slopes of the lines for Sry+ and Sry−, they were signiﬁcantly
different (Supplementary Table 3). Thus, FCG GBM astrocytes
isolated from mice that were gonadally female had a signiﬁcant
relationship between p21 and senescence, as measured by SA-βgal. This suggests that gonadal sex, and the epigenetic effects of in
utero gonadal hormones, patterns the role of p21 in senescence
induction in response to irradiation.
Discussion
Glioblastoma remains an incurable disease, with limited treatment options. Surgical resection, followed by radiation and chemotherapy remains the most effective treatment strategy. A better
understanding of the mechanisms underlying the therapeutic
response to radiation may help enhance treatment efﬁcacy. Here
we show that radiation response correlates with different molecular signatures in male and female human GBM lines. Using a
mouse model of GBM, we further identify increased sensitivity to
radiation in female GBM astrocytes, and determine that both
non-apoptotic cell death and cellular senescence likely contribute
to sex differences in radiation response. With a correlation-based
approach, we identiﬁed p21 as a likely mediator of irradiationinduced senescence. Strikingly, the relationship between p21 and
the senescence marker SA-β-gal signiﬁcantly differed in male and
female cells—a ﬁnding that was observed in mouse GBM model
astrocytes, mouse wildtype astrocytes, and primary human GBM
lines. Female cells had higher levels of senescence, as measured by
SA-β-gal, in response to the same levels of p21—suggesting that
p21 plays a more critical role in irradiation-induced cellular
senescence in female than in male cells. This ﬁnding was conﬁrmed by p21 knockdown, which decreased the percentage of
senescent cells in female GBM model astrocytes to levels similar
to those of males. Importantly, the relationship between SA-β-gal
and p21 was evident across the heterogeneous p53 status of the
varying murine models (wildtype, dominant negative, CRISPR
deletion) and the heterogeneous nature of the human GBM cell
lines. Together, these results indicate that the sex differences in
p21-induced senescence are p53 independent. Finally, using a
novel FCG model of GBM, which enables mechanistic dissection
of the biological underpinnings of a sex difference, we determined
that the relationship between p21 and irradiation-induced cellular
senescence is patterned by gonadal sex. This ﬁnding will help
guide future studies that aim to uncover the pathways regulating
the p21-senescence axis and eventually modulate this interaction
to improve radiation response in both sexes.
Our results highlight some intriguing directions for future
studies. Interestingly, when p21 was knocked down in female
GBM model astrocytes, it did not eliminate the senescence
response to irradiation, but did abrogate the sex difference in
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Fig. 8 Gonadal sex patterns the relationship between p21 and SA-β-gal positivity. a Diagram of the four genotypes resulting from the FCG mouse model.
b Example images of FCG GBM model astrocytes stained for SA-β-gal 5 days after irradiation with 0 or 8 Gy, followed by counterstaining with nuclear fast
red. Scale bar, 150 μm. c Quantiﬁcation of the percentage of SA-β-gal positive cells. Results are from two cell lines (each consisting of a corresponding XY
+, XY−, XX+, and XX− line generated at the same time) tested in two separate experiments. Values were normalized to the XY + 0 Gy condition, which
was arbitrarily set at 1. *p < 0.05 as indicated by bracket. Data are means +/− SEM (n = 4/genotype/condition). d Correlation between Cdkn1a (p21)
mRNA levels at 24 h after irradiation with 0 or 8 Gy and the percentage of SA-β-gal positive cells at 5 days after irradiation in FCG GBM model astrocytes,
showing each genotype separately (left), as well as grouped by sex chromosomes (center) or gonadal sex (Sry status) (right). Sry+ correlation: r = 0.13,
p = 0.7617, Sry- correlation: r = 0.91, p = 0.0016 (n = 8/group). e Correlation between the Cdkn1a/Cdk2 mRNA ratio at 24 h after irradiation with 0 or 8 Gy
and the percentage of SA-β-gal positive cells at 5 days after irradiation in FCG GBM model astrocytes, showing each genotype separately (left), as well as
grouped by sex chromosomes (center) or gonadal sex (Sry status) (right). Sry+ correlation: r = −0.22, p = 0.5964, Sry− correlation: r = 0.91, p = 0.002.
Sry+ slope vs Sry− slope: p = 0.0262—indicated by bracket (n = 8/group).

response. This suggests that there are additional pathway(s),
beyond p21, contributing to senescence induction after radiation,
and that these are shared by males and females. Which signaling

pathways, and whether they are always active or are upregulated
with p21 loss, remains to be determined. Another avenue of
future direction is uncovering how gonadal sex patterns the
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relationship between p21 and senescence. Our ﬁndings suggest
that the testosterone surge in utero (or lack thereof in females) is
responsible for the sex differences in the p21-senescence axis. The
hormone surge has been shown to exert long-term organizational
effects in the brain through epigenetic mechanisms1,31. However,
the differences we observe are not explained through simple
regulation of accessibility at the p21 locus, since equivalent levels
of p21 in males and females correspond to different percentages
of SA-β-gal positive cells. Instead, differences in hormone exposure in utero may regulate proteins that inﬂuence p21 localization
or activity through post-translational modiﬁcations32–35. Future
studies will investigate this possibility, with the goal of enhancing
the senescence response after irradiation.
We also observed a sex difference in the levels of SA-β-gal cells
in male and female wild-type astrocytes with advanced population doublings in vitro. This suggests female cells may be more
susceptible to replicative senescence and/or to oxidative stress,
since cells were grown at supraphysiological oxygen levels27. This
has important implications for the ﬁelds of aging and neurodegenerative disease. Senescent cells contribute to a wide range of
normal and pathological changes with aging36,37, and are
increasingly thought to play a role in neurodegenerative
disease38,39. Sex differences in p16 and p21 expression in aged
mice in vivo have been reported, although this study actually
found higher levels in male mice than female mice40. In our
study, the same levels of p21 were associated with increased SA-βgal cells in females, raising the possibility that this difference may
not actually translate into increased senescent cells in males.
Alternatively, it is possible that the senescent cell phenotype may
also differ between male and female cells. The senescenceassociated secretory phenotype varies based on cell type and
senescence induction mechanism21,41, and so could reasonably be
inﬂuenced by cell sex. This could potentially result in different
rates of clearance for male and female senescent cells in vivo, or
mean that the same levels of senescence have different effects on
the surrounding tissue depending on sex.
One of the potential limitations of our study is that we rely on
SA-β-gal for our primary measure of senescence. While SA-β-gal
is the most widely used marker of senescence, there is debate
about its speciﬁcity, since it is not required for senescence
induction and has been observed in non-senescent cells19. In
support of the idea that SA-β-gal does correspond to senescence
in our study: (1) it increased with exposure to radiation in a dosedependent manner, (2) along with increases in SA-β-gal, we saw
more cells with an enlarged, irregular shape, (3) cell cycle arrest
was conﬁrmed by a decrease in EdU incorporation and in the
percent of cells positive for the proliferation marker Ki67, (4)
expression changes consistent with ionizing radiation-induced
senescence were observed in our cells, and (5) levels of the cell
cycle inhibitor p21 also increased. Regardless of whether SA-β-gal
is a measure of true senescence, our ﬁndings still have important
implications for the ﬁeld. When interpreting studies that use p21
as a marker of senescence, it may be necessary to consider the sex
of the subjects, and whether the same pathway could have differences in downstream outcomes between male and female cells.
Finally, our results highlight the utility of correlation analyses
when studying sex differences. Most phenotypes are not truly
sexually dimorphic, but represent a spectrum of values in males
and females. While the mean values differ, and the two ends of
the spectrum are populated primarily by individuals of one sex or
another, there is considerable overlap. In addition, the variability
between individuals of a single sex may obscure the differences
between the two sexes, requiring a large sample size to detect the
difference. With our approach, we discovered a difference in the
relationship between p21 and SA-β-gal in males and females that
was not apparent when we simply compared mean p21 levels
14

alone. This could offer a powerful investigation strategy that takes
advantage of individual variability rather than viewing it as a
liability.
In summary, we have uncovered a sex difference in the relationship between p21 and irradiation-induced cellular senescence
that has potential implications for the ﬁelds of cancer research,
neuroscience, and aging. Better understanding of this mechanism
could identify novel approaches to improve response to cancer
therapy.
Methods
Primary human GBM lines. Primary human GBM lines were kindly provided by
Dr. Albert H. Kim. Specimens for culture were obtained prospectively at the time of
surgery and cell lines were established42. Consent was obtained in accordance with
a Washington University Institutional Review Board (IRB) approved Human
Studies Protocol. Patient charts were reviewed for the molecular characteristics of
the tumors/GBM lines (Supplementary Table 1). Available information varied
between tumors; where no information was available, that cell in the table was left
blank. Human GBM lines were grown on laminin (Sigma) coated Primaria plates
in RHB-A media (Takara) supplemented with growth factors EGF (Sigma) and
bFGF (Millipore) at 50 ng/ml. Media was replaced with half fresh media every
2–3 days. For passaging, cells were detached with Accutase (Sigma) and split 1:2 to
1:4 depending on cell line. One female human line (B51) was excluded from the
SA-β-gal studies, since these cells did not attach to glass coverslips, even when
coverslips were coated with laminin.
Mouse wild-type astrocytes. All animals were used in accordance with an Animal Studies Protocol approved by the Animal Studies Committee of the
Washington University School of Medicine, per the recommendations of the Guide
for the Care and Use of Laboratory Animals (NIH). Mouse wildtype astrocytes
were isolated from the cortex of postnatal day 1 C57BL/6J pups as described13.
Brieﬂy, the cortices were dissected from the rest of the brain in cold HBSS and the
meninges were removed. Isolated cortices were incubated in 500 μl 0.05% TrypsinEDTA + 0.02 mg/mL DNase I (Roche) for 15 min at 37 °C. Trypsin was neutralized
by the addition of 750 μl media (DMEM/F12 + 10% FBS + 1% penicillin-streptomycin), and tissue was triturated 10–15 times with a p1000 pipet, then ﬁltered
through a 40 μm cell strainer. Cell suspension was spun down, and the pellet was
resuspended and plated in a poly-L-lysine (ScienCell) coated T25 ﬂask. Cells were
grown until conﬂuent (~7 days). To obtain a pure population of astrocytes, conﬂuent ﬂasks were shaken at 225 rpm overnight at 37 °C. After shaking, the media
was aspirated, removing any ﬂoating cells, and ﬂasks were rinsed once with sterile
PBS. The remaining attached cells, representing the astrocyte population, were
trypsinized and replated in Primaria T75 ﬂasks (Corning). Cells were then
expanded for downstream analyses. Prior to experimental treatment, cells were
switched to media without penicillin/streptomycin (DMEM/F12 + 10% FBS). For
the irradiation studies, all data points represent astrocyte cultures from individual
pups. The sex of each culture was determined by genotyping the corresponding
pup tail DNA for the X and Y chromosome paralogs Kdm5c (Jarid1c) and Kdm5d
(Jarid1d) (Forward: CTG AAG CTT TTG GCT TTG AG, Reverse: CCA CTG CCA
AAT TCT TTG G)43. All irradiation studies were carried out on astrocytes that
were passage 2 or 3. For the studies of astrocytes at low and high population
doubling levels, cultures from multiple pups were pooled by sex to generate male
and female cultures.
Mouse GBM model astrocytes. Brieﬂy, astrocytes were isolated from the cortex of
postnatal day 1 Nf1ﬂox/ﬂox;GFAP-Cre mouse pups as detailed above. Sex was
determined by genotyping pup tail DNA for the X and Y chromosome paralogs
Kdm5c (Jarid1c) and Kdm5d (Jarid1d)43. Astrocytes from at least three male and
three female pups were then pooled by sex. Male and female Nf1−/− astrocyte
cultures were infected with a retrovirus encoding EGFP and a ﬂag-tagged dominant-negative p53 (DNp53), consisting of amino acids 1–14 of the transactivation
domain, followed by amino acids 309–393. GFP positive-DNp53 expressing cells
were selected for using ﬂuorescence-activated cell sorting (FACS). Nf1−/− DNP53
cells were cultured in DMEM/F12 supplemented with 10% FBS and 1% penicillinstreptomycin. Five individually generated Nf1−/− DNp53 cell lines, each consisting of a paired male and female line, were used for the experiments in this
study13.
p21 knockdown lines. Brieﬂy, male and female Nf1−/− DNp53 astrocytes were
infected with the lentiviral Cas9/sgRNA-p21 all-in-one construct (p21 sgRNA
sequence: ACTTCGTCTGGGAGCGCGTT). Cas9 control lines were generated by
infecting with the lentiviral Cas9 vector without any guide RNA. Following
infection, cell lines were selected by puromycin treatment (2.5 μg/ml) for
1–2 weeks. Surviving cells were expanded and p21 knockdown was conﬁrmed by
western blot14.
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FCG GBM model astrocytes. To generate the FCG-GBM model, Four Core
Genotypes XY-/Sry+ male mice30,44–46 (Jackson Laboratory #010905) were bred
with constitutive Cas9 expressing47 female mice (Jackson Laboratory #026179), and
astrocytes were isolated from the cortex of postnatal day 1 FCG-Cas9 mouse pups
as described13. Pup tail DNA was genotyped for Sry and the Y chromosome
following the protocol available from Jackson Laboratory (Sry Forward: AGC CCT
ACA GCC ACA TGA TA, Sry Reverse: GTC TTG CCT GTA TGT GAT GG, Y
Chrom. Forward: CTG GAG CTC TAC AGT GAT GA, Y Chrom. Reverse: CAG
TTA CCA ATC AAC ACA TCA C, Internal Control Forward: CAA ATG TTG
CTT GTC TGG TG, Internal Control Reverse: GTC AGT CGA GTG CAC AGT
TT). Astrocytes from at least three pups from each of the four genotypes were
pooled to generate XY−/Sry+ (XY+), XY−/Sry− (XY−), XX/Sry+ (XX+), and
XX/Sry− (XX−) cultures. FCG-Cas9 astrocytes at passage 4 were transfected with a
modiﬁed pX330 vector with dual sgRNAs targeting Nf1 and p53 (Nf1 sgRNA
sequence: GCAGATGAGCCGCCACATCGA, p53 sgRNA sequence:
CCTCGAGCTCCCTCTGAGCC). The pX330-Nf1-p53 vector was kindly provided
by Dr. Kwanha Yu and Dr. Benjamin Deneen (Baylor College of Medicine). FCGCas9 astrocytes that received the pX330-Nf1-p53 plasmid were immortalized and
had a signiﬁcant growth advantage. Since wildtype astrocytes stop dividing after
passage 5–6, growth advantage was used to select for astrocytes with successful
CRISPR mutation/deletion of Nf1 and p53. FCG-Cas9 Nf1/p53 CRISPR astrocytes
were passaged at least three times, then protein was collected for conﬁrmation of
Nf1 and p53 knockdown by western blot.
Irradiation. For irradiation experiments, cells were irradiated using an RS 2000
X-ray irradiator (Rad Source Technologies) unless otherwise speciﬁed in the speciﬁc methods section. Radiation was delivered at a dose rate of ~1.8 Gy/min with
160 kVp X-rays. Control cells were transported to the irradiator and sat on the
bench for the same length of time as cells were in the irradiator.
Human GBM irradiation dose-response curves. Human GBM cells were lifted
with Accutase, counted, and 20,000 cells per well were plated in laminin (Sigma)
coated 24-well plates. Cells were plated in triplicate wells for each irradiation dose.
Cells were irradiated 24 h later with 0, 2, 4, 6, 8, or 10 Gy, then allowed to grow for
4 days, with fresh media added to the wells 2 days after irradiation. On day 4,
media was aspirated off, and 200 μl of Accutase was added to each well. Plates were
incubated for 3 min in a 37 °C incubator, then wells were rinsed with Accutase to
detach all cells, and cell suspension was transferred to 1.7 ml tubes on ice. Cell
suspension was diluted 1:1 with Trypan blue, and cells were counted with a
hemocytometer. Three technical replicates were counted per dose. Percentage of
cell number was calculated by dividing the counts for each dose by the average cell
number for the 0 Gy condition. For all cell lines except B5, two separate dose curves
were performed, and the six technical replicates were combined to get the ﬁnal
irradiation dose response curve. Due to slow growth rate, B5 cell number was
limited, and only one dose curve, with three technical replicates, was performed.
Mouse GBM irradiation dose response curves. Irradiation dose response curves
for mouse GBM model astrocytes were performed using the sulforhodamine B
assay as described, with minor modiﬁcations48. Brieﬂy, Nf1−/− DNp53 astrocytes
were trypsinized, counted, and 1000 cells per well in 200 μl media were plated in
96-well white-walled clear-bottom plates (Corning). Six technical replicate wells
were plated for each irradiation dose. A standard curve for each cell line and sex
was plated at the same time by performing a twofold serial dilution starting at
100,000 cells per well, and diluting six times, plating 0 cells in the ﬁnal row.
Standard curve wells were plated in triplicate for each cell line. 6 h after plating,
standard curves were ﬁxed by the addition of 100 μl ice cold 5% trichloroacetic acid
and incubating at 4 °C for 1 h. Standard curve plates were then washed four times
with tap water and allowed to dry overnight. 24 h after plating, cells were irradiated
with 0, 2, 3, 4, 6, 8, or 9 Gy, then allowed to grow for 4 days. On day 4, plates were
ﬁxed with 5% trichloroacetic acid, then washed and dried. After drying, plates were
stained by adding 100 μl of 0.057% sulforhodamine B (SRB) diluted in 1% acetic
acid to each well and incubating for 30 min at room temperature. Plates were then
washed three times with 1% acetic acid and allowed to dry overnight. SRB was
solubilized by adding 100 μl 10 mM Tris-Base (pH 10.5) to each well, then incubating for 1–2 h at room temperature on a shaker. Absorbance was measured at
510 nm using an Inﬁnite 200 PRO microplate reader (Tecan). Standard curve
absorbance values were graphed using GraphPad Prism software, and a linear
standard curve was ﬁt. The standard curve for each cell line was used to interpolate
the cell number for experimental wells. Percentage of cell number was calculated by
dividing the cell counts for each irradiated well by the average cell number for the
0 Gy condition. Technical replicates were averaged to derive a single value for each
dose per cell line and sex, and results from each of the 5 Nf1−/− DNp53 cell lines
were combined to generate the ﬁnal irradiation dose response curves for male and
female mouse GBM model astrocytes.
Cell growth assays via live cell imaging. Cells were plated at 1000 cells per well
into a 96-well plate with ﬁve technical replicates plated per condition. Cells were
irradiated using a GammaCell 40 Irradiator (Best Theratronics). Non-irradiated
plates were transported to the radiation facility, but not exposed. The 96-well plates
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were then immediately placed into the IncuCyte ZOOM live cell imaging system
(Satorius). Phase-contrast images were taken every 4 h for a total of 72 h with
4 scan areas taken per well. Cell conﬂuence was analyzed using the IncuCyte
ZOOM analysis software. Percent conﬂuence over time was used as a measure of
longitudinal cell growth.
Clonogenic assay. Cells were plated at 500 cells per well into six-well plates. The
next day, cells were either left unirradiated (0 Gy) or irradiated with 4, 8, 12, or
16 Gy using a GammaCell 40 Irradiator (Best Theratronics). Media was changed
24 h after irradiation. Five days post-treatment, cells were washed in 1× PBS, before
being ﬁxed with 100% methanol for 10 min and stained with a 0.5% crystal violet
solution for 30 min. Plates were imaged the next day on the LI-COR Odyssey near
infrared imaging system and analyzed via a custom ImageJ macro which counts
individual colonies, allowing for unbiased quantiﬁcation.
Immunoﬂuorescence for γH2AX. Cells were plated at 20,000 cells per well onto
coverslips within the wells of 24-well plates. Twenty-four hours post plating, cells
were left un-irradiated (0 Gy) or irradiated with 3 Gy or 8 Gy using a GammaCell
40 Irradiator (Best Theratronics). Coverslips were harvested and ﬁxed with MeOH
at 1, 6, 24, and 48 h post-irradiation. Cells were then processed for immunoﬂuorescence for γH2AX (1:500; Millipore, 05–636 JBW301). Secondary detection
was accomplished using Alexa Fluor 488 goat anti-mouse IgG (1:500; Invitrogen,
A28181). Nuclei were counterstained with Hoechst. Images were acquired using a
Leica DM5500B upright epiﬂuorescence microscope for a total number of 100–200
cells analyzed per n. Cells were scored as having more or less than 10 γH2AX foci.
Western blot analysis. For protein collection, plates were rinsed once with cold
PBS, then cells were lysed with RIPA buffer plus cOmplete™ Protease Inhibitor
Cocktail (Roche), PhosStop Phosphatase Inhibitor Cocktail (Roche), and PMSF.
Cell lysates were left on ice for 10 min, vortexing every 2 min, then frozen at
−80 °C. Before use, lysates were thawed and spun at 16,000 × g for 15 min at 4 °C.
Supernatant was collected and used for downstream analyses. Protein concentration was measured with the DC Protein Assay (Bio-Rad), following the manufacturer’s microplate assay protocol, and using an Inﬁnite 200 PRO microplate
reader (Tecan) to measure absorbance. Total protein lysate was combined with
NuPAGE LDS Sample Buffer (Invitrogen) and NuPAGE Sample Reducing Agent
(Invitrogen), then samples were heated for 10 min at 95 °C. For Nf1−/− DNp53
astrocyte and Nf1−/− DNp53 Cas9 and p21 KD samples, 100 μg of protein was
loaded, and samples were run on a NuPAGE 4–12% Bis-Tris Gel in MES SDS
Running Buffer (Invitrogen). For wild-type mouse astrocyte and human GBM
samples, 30 μg of protein was loaded, and samples were run on a NuPAGE 4–12%
Bis-Tris Gel in MES SDS Running Buffer (Invitrogen). For FCG-Cas9 and FCGCas9 Nf1/p53 CRISPR samples, 75 μg of protein was loaded and samples were run
on a NuPAGE 4–12% Bis-Tris Gel in MOPS SDS Running Buffer (Invitrogen).
After separation by electrophoresis, proteins were transferred to Odyssey nitrocellulose membrane (LI-COR). Membranes were blocked for 1 h at room temperature in Odyssey Blocking Buffer (LI-COR) or Intercept (PBS) Blocking Buffer
(LI-COR) diluted 1:1 with PBS-T. Membranes were incubated overnight in primary antibody diluted in blocking buffer (1:1000 anti-cleaved caspase-3 Cell Signaling Technologies #9664, 1:4000 anti-α-Tubulin Sigma #T5168, 1:1000 antiPARP Cell Signaling Technologies #9542, 1:2000 anti-mouse p21 Abcam
#ab188224, 1:1000 anti-Cdk2 Cell Signaling Technologies #2546, 1:1000 antihuman p21 Cell Signaling Technologies #2947, 1:200 anti-Nf1 Santa Cruz #sc376886, 1:1000 anti-p53 Sigma #T5168, 1:25,000 anti-Actin Sigma #A1978).
Membranes were washed with PBS-T then incubated in secondary antibody diluted
in blocking buffer for 1 h at room temperature (1:30,000 IRDye 680RD Donkey
anti-Rabbit or Donkey anti-mouse, 1:20,000 IRDye 800CW Donkey anti-Rabbit or
Donkey anti-mouse (LI-COR)). Membranes were washed in PBS-T, then proteins
were visualized using a ChemiDoc MP Imaging System (Bio-Rad). Band intensity
was quantiﬁed using Image Lab Software Version 6.0.0 (Bio-Rad).
Flow cytometric analysis of EdU/PI and Annexin-V staining. Cells were seeded
at a density of 2 × 105 (females) and 1 × 105 (males) in T25 ﬂasks and cultured in
DMEM/F12 with 10% FBS and 1% penicillin-streptomycin. The next day cells were
treated with 0, 3, 6 or 8 Gy irradiation (IR) and returned to the incubator. Cell cycle
analysis was conducted at 24 h after irradiation. Annexin-V staining was conducted
at 24 h and 5 days after irradiation. Brieﬂy, cells were treated with 10 μM EdU for
1 h in their optimum growth culture condition to allow for EdU incorporation into
active DNA synthesis. They were then harvested using trypsin, along with their
media to include the ﬂoaters, and counted using a Countess 3 automated cell
counter (Invitrogen, AMQAX2000). Live versus dead cells were determined using
trypan blue exclusion. Cells were strained through a 70 μM ﬁlter and divided into
two tubes, one for Annexin-V labeling and one for EdU-PI labeling. A total of
3 × 105 cells were used for each stain. Annexin-V: For annexin-V staining, cells
were labeled with 5 μl Annexin-V (Paciﬁc Blue, Invitrogen, A35122) in 100 μL 1X
Annexin-V binding buffer (Invitrogen, V13246) for 15 min in the dark at room
temperature. After 15 min incubation, 400 μl of 1X Annexin-V binding buffer was
added to each sample and FACS analyzed using the CytoFlex S Flow Cytometer
(Beckman Coulter, CO2949). Etoposide (ﬁnal concentration of 20 μg) was used as a
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positive indicator of apoptosis. Edu-PI: For EdU-PI staining, cells were prepared
and resuspended in 1X Click-iT™ permeabilization and wash reagent per the
manufacturer’s instructions (Invitrogen, C10636). Detection of Click-iT EdU was
followed immediately by incubating the cells with the Click-iT Plus reaction
cocktail (438 μL PBS, 10 μL copper protectant, 2.5 μL ﬂuorescent dye picolyl azide,
50 μL reaction buffer additive per sample) for 30 min at room temperature, protected from light. Cells were then washed with 3 mL 1X Click-iT™ permeabilization
and wash reagent, centrifuged, and resuspended in 200 μL of 1X Click-iT permeabilization and wash reagent containing 0.3 μL PI, and FACS analyzed using the
CytoFlex S Flow Cytometer (Beckman Coulter, CO2949). Unstained samples and
cells that had been serum-starved for 48 h were used as controls for demarcating
background/autoﬂuorescence staining and to demarcate the cell cycle arrest at G0/
G1, respectively.

Senescence-associated β-galactosidase staining. For Nf1−/− DNp53 astrocytes
and FCG GBM model astrocytes, cells were plated in six-well plates at ~70%
conﬂuence (70,000–100,000 cells per well depending on cell line/sex) and irradiated
24 h later. Four days after irradiation, cells were lifted, counted, and plated on polyL-lysine (ScienCell) coated glass coverslips in 24-well plates at sub-conﬂuency
(15,000 cells per well). Twenty-four hours later, cells were stained using the
Senescence Associated β-galactosidase Staining Kit from Cell Signaling Technologies, according to the manufacturer’s instructions. Brieﬂy, cells were washed once
with PBS, then ﬁxed for 15 min with provided Fixative Solution. After ﬁxing, cells
were rinsed twice with PBS, then incubated in β-galactosidase staining solution (pH
5.9–6.1) overnight (~16 h) in a 37 °C dry incubator. The next morning, staining
solution was removed and cells were rinsed twice with PBS. For mouse wild-type
astrocytes, cells were grown in Primaria 6 well plates and irradiated at ~70%
conﬂuence. 5 days after irradiation, cells were lifted, counted, and plated on poly-Llysine coated glass coverslips in 24-well plates at sub-conﬂuency (27,500 cells per
well). Forty-eight hours later, cells were stained using the Senescence Associated βgalactosidase Staining Kit. For human GBM lines, cells were grown in laminincoated six-well plates and irradiated at ~70% conﬂuence. Four days after irradiation, cells were lifted, counted, and plated on laminin-coated glass coverslips in 24well plates at sub-conﬂuency (25,000 cells per well). Twenty-four hours later, cells
were stained using the Senescence Associated β-galactosidase Staining Kit. After
SA-β-gal staining, cells were counterstained with Nuclear Fast Red (Vector
Laboratories), following the manufacturer’s instructions. Coverslips were dehydrated then mounted on slides using Permount Mounting Medium (Fisher) diluted
2:1 with Xylene substitute. Images were taken on a Zeiss Axio Scope A1 upright
light microscope at 10× magniﬁcation. Total cells and positive cells were counted
by hand in ImageJ (FIJI Version 2.1.0) using the Cell Counter plugin. All images
were taken and quantiﬁed by an experimenter blinded to the sex and experimental
condition of the sample.

Immunocytochemistry for Ki67 and Geminin. Ki67: Nf1−/− DNp53 astrocytes
were plated in six-well plates at ~70% conﬂuence and irradiated the following day.
Four days after irradiation, cells were trypsinized and counted, and 15,000 cells per
well were plated on poly-L-lysine (ScienCell) coated glass coverslips in 24-well
plates. Twenty-four hours later cells were washed once with PBS, then ﬁxed with
3.2% paraformaldehyde (Electron Microscopy Sciences) for 15 min. Cells were then
washed twice with PBS and stored at 4 °C until staining was performed. For Ki67
immunocytochemistry, cells were permeabilized with 0.2% Triton-X 100 for
15 min at room temperature and nonspeciﬁc antibody staining was blocked with
antibody diluent (10% normal donkey serum, 1% bovine serum albumin (BSA) and
0.2% Triton-X 100 in PBS) for 1 h at room temperature. Cells were then incubated
in rabbit anti-Ki67 (Abcam ab15580, 1:500) or rabbit IgG control (Cell Signaling)
overnight at 4 °C, after which cells were washed and incubated in donkey antirabbit Alexa Fluor 555 (Invitrogen, 1:1000) for 1 h at room temperature. Nuclei
were stained with DAPI for 1 min, then coverslips were mounted in Immu-Mount
(Thermo Fisher Scientiﬁc). Images were taken on an Olympus BX60 (Olympus,
Japan) ﬂuorescence microscope at 10× magniﬁcation. Ki67 images were taken at
500 ms exposure. Color images were converted to 16 bit and thresholded in ImageJ.
Thresholds were determined using IgG controls. After thresholding, cell number
was counted with the automated cell counter (Analyze Particles); anything <60
pixel2 was excluded from the count. The positive rate is the ratio of stained cells to
total cells. All images were taken and quantiﬁed by an experimenter blinded to the
sex and experimental condition of the sample. Geminin: Mouse wildtype astrocytes
were grown in Primaria 6 well plates and irradiated at ~70% conﬂuence. Five days
after irradiation, cells were lifted, counted, and plated on poly-L-lysine coated glass
coverslips in 24-well plates at sub-conﬂuency (27,500 cells per well). Forty-eight
hours later, cells were washed once with PBS, then ﬁxed with 3.2% paraformaldehyde for 15 min. Cells were then washed twice with PBS and stored at 4 °C
until staining was performed. For Geminin staining, cells were permeabilized with
0.2% Triton-X 100 in PBS, and processed for immunoﬂuorescence as described
above for Ki67. Geminin was localized with anti-geminin antibody (Abcam
ab175799, 1:1000) and secondary detection was accomplished with donkey antirabbit Alexa Fluor 555 (Invitrogen a31572, 1:1250). Total numbers of gemininpositive cells were counted by a blinded observer.
16

RNA isolation and cDNA preparation – Mouse GBM model astrocytes. RNA
was isolated from Nf1−/− DNp53 astrocytes and FCG GBM model astrocytes
using TRIzol Reagent (Invitrogen), following the manufacturer’s protocol. Brieﬂy,
cells were grown in 10-cm dishes to ~70% conﬂuence, then irradiated. At desired
timepoint after irradiation, media was aspirated, and cells were washed once with
cold PBS. 1 ml of Trizol was added to the dish; cells were scraped into Trizol,
allowed to sit 5 min at room temperature, then transferred to a 1.7 ml tube. 200 μl
of chloroform was added, and samples were shaken vigorously for 15 s, then sat at
room temperature for 3 min. Samples were spun at 12,000 × g for 15 min at 4 °C.
The aqueous phase was transferred to a new tube, and 500 μl of isopropyl alcohol
was added to precipitate RNA. Samples were incubated for 10 min at room temperature, then spun at 12,000 × g for 10 min at 4 °C. Supernatant was aspirated, and
pellet was washed with 1 ml cold 75% ethanol. Samples were spun at 7500 × g for
5 min at 4 °C and ethanol was aspirated. After drying, pellet was resuspended in
35 μl molecular biology grade water (DNase/RNase free). RNA concentration was
measured with a NanoDrop 1000 spectrophotometer (Thermo Scientiﬁc). RNA
was treated with Ampliﬁcation Grade DNAse I (Invitrogen) to eliminate genomic
DNA, and cDNA was generated using the SuperScript III First-Strand Synthesis
System (Invitrogen), according to the manufacturer’s instructions.
RNA isolation and cDNA preparation – Mouse wildtype astrocytes. RNA was
isolated from mouse wildtype astrocytes using the QIAGEN RNeasy Mini Kit,
according to the manufacturer’s instructions. Brieﬂy, astrocytes were grown in 10cm Primaria dishes to ~70% conﬂuence, then irradiated. At desired timepoint after
irradiation, media was aspirated, and cells were washed once with cold PBS. 350 μl
of RLT buffer + β-mercaptoethanol was added and cells were scraped into RLT
buffer, then transferred to a 1.7 ml tube. Cells were homogenized by passing
through a 20-gauge needle attached to a 1 ml syringe ~10 times, then 350 μl of 70%
ethanol was added to the cell lysate and mixed by pipetting, before transferring to
the RNeasy spin column. To eliminate genomic DNA, the optional on column
DNase digestion was performed by adding 80 μl DNase I solution (QIAGEN) to
the column membrane and incubating 15 min at room temperature. RNA was
eluted by adding 30 μl molecular biology grade water (DNase/RNase free) directly
to the column membrane, incubating at room temperature for 2.5 min, then
spinning at 10,000 × g for 1 min. RNA concentration was measured with a
NanoDrop 1000 spectrophotometer (Thermo Scientiﬁc). cDNA was generated
using the QuantiTect Reverse Transcription Kit (QIAGEN) following the manufacturer’s instructions.
Quantitative real-time PCR. Quantitative RT-PCR was performed using genespeciﬁc primers and iTaq Universal SYBR Green Supermix (Bio-Rad). A standard
curve was generated for each experiment by pooling cDNA from all samples and
serially diluting to generate concentrations of 25, 12.5, 6.25, and 3.125 ng/μl.
Samples were diluted to a concentration of 10 ng/μl. 2 μl of sample or standard was
loaded in each well, and two technical replicates were run for each sample. A CFX
Connect Real-Time PCR Detection System (Bio-Rad) was used to collect and
analyze the ampliﬁcation data. Analyses of standard curves, melt curves, and
reverse-transcriptase-negative controls were used to verify primer and ampliﬁcation reaction quality. Expression levels of genes of interest were normalized to the
average expression of three housekeeping genes: Gapdh, Actb, Rpl5. Primer
sequences: Actb (Forward: TGT ATT CCC CTC CAT CGT G, Reverse: CGC AGC
TCA TTG TAG AA GG), Ccnd1 (Forward: GTG CAT CTA CAC TGA CAA CTC,
Reverse: TGG TCT GCT TGT TCT CAT CC), Cdk2 (Forward: GCA CCA GGA
CCT CAA GAA AT, Reverse: ACG GTG AGA ATG GCA GAA AG), Cdkn1a
(Forward: AGA CAT TCA GAG CCA CAG GCA CCA, Reverse: GCA TCG CAA
TCA CGG CGC AA), Cdkn1b (Forward: TGG TGG ACC AAA TGC CTG AC,
Reverse: TTC GGG GAA CCG TCT GAA AC), Cdkn2a (Forward: GAC ATC GTG
CGA TAT TTG CGT TCC G, Reverse: TTT AGC TCT GCT CTT GGG ATT GGC
C), Gapdh (Forward: GGC AAA TTC AAC GGC ACA GT, Reverse: AGA TGG
TGA TGG GCT TCC C), Rpl5 (Forward: GGA AGC ACA TCA TGG GTC AGA,
Reverse: TAC GCA TCT TCA TCT TCC TCC ATT), Xist (Forward: GCT GTA
GTA GTC ACA GTC CCA, Reverse: CTG TGT TTG CCC CTT TGC TA).
Statistics and reproducibility. Data were graphed and statistical analyses,
including two-way ANOVAs, t-tests, one sample t-tests and dose response curves,
were performed using GraphPad Prism software (Prism 9 for macOS Version
9.0.0). All tests were two-tailed unless otherwise speciﬁed. The two-way ANOVA
models ﬁt the effect of sex, time or dosage, and their interaction. Dose response
curves were ﬁt to normalized response versus dosage using the 4-parameter logistic
regression dose-response model with the slopes estimated by maximizing the
likelihood function. For Nf1−/− DNp53 graphs normalized to the Male 0 Gy
condition of the same cell line (Figs. 3a–c, 7b–d, and Supplementary Fig. 2), the
Male 0 Gy values were derived by dividing by the Male 0 Gy average. Spearman
rank-based correlation analysis between IC50 and gene expression was performed
as described7 using R (version 3.5.0). Brieﬂy, Spearman correlation coefﬁcients of
irradiation IC50 values with expression of either MC5 genes (17 genes), FC3 genes
(9 genes), or randomly selected gene sets of the same size, were calculated. The
Olkin-averaged Spearman correlation coefﬁcients with IC50 across MC5 genes and
across FC3 genes per cell line was summarized and tested against 0 with those

COMMUNICATIONS BIOLOGY | (2022)5:781 | https://doi.org/10.1038/s42003-022-03743-9 | www.nature.com/commsbio

COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-022-03743-9

derived for 1000 random gene sets serving as negative control. To explore the
relationship between senescence and the various molecular markers focused on
p16, p21, and p21/CDK2 ratio, linear regression analysis and Pearson’s correlation
analysis was conducted using R (version 4.0.2). Pearson’s correlation coefﬁcients (r)
were calculated and the Fisher’s Z transformed coefﬁcients were compared between
sex by normal test. In the integrative linear regression modeling across sex, the
dependent/outcome variable was senescence, as measured by SA-β-gal, while the
independent/predictor variable included the continuous mRNA or protein levels of
the molecular marker of interest and sex. To assess the possible linear association
between SA-β-gal and each of the continuous variables by sex, sex-speciﬁc intercepts and slopes were estimated from the integrative linear models. The slope
difference between the male and female-speciﬁc slopes was derived with 95%
conﬁdence interval (CI) and tested against 0 by the two-sided Wald test. Signiﬁcance was claimed at p < 0.05. Detailed slope and correlation estimation results
can be found in Supplementary Table 3. For the Nf1−/− DNp53 mRNA correlations only, mRNA expression levels from cells irradiated with 0, 6 or 9 Gy were
correlated with SA-β-gal results from cells irradiated with 0, 6, or 8 Gy—thus
resulting in a correlation consisting of 0, 6, and 8/9 Gy doses. For all other correlations, irradiation levels were exactly the same for protein/mRNA measures and
SA-β-gal.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
The source data for all ﬁgures and tables is presented in the Supplementary Data ﬁle.
Uncropped and unedited western blot images are also available in the Supplementary
Data File. Any additional details can be requested from the corresponding author.
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